Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Burkitt Lymphoma 7Meningeal Carcinomatosis 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 4Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Meningeal Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Uveal Melanoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Nevus 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Monocytic, Acute 1Leukemia, Hairy Cell 1Leukemia, Biphenotypic, Acute 1Hematopoietic and Lymphatic System Neoplasm 1Germinoma 1Down Syndrome 1Diabetes Insipidus 1Brain Neoplasms 1

Interventions

Practice Guidelines as Topic 7Interviews as Topic 7Standard of Care 6Specimen Handling 6Educational Status 4Patient Navigation 3Telemedicine 2Methods 2Health Promotion 2Early Intervention, Educational 2Behavior Therapy 2theanine 1ruxolitinib 1merphos 1Triptorelin Pamoate 1Spinal Puncture 1Parenteral Nutrition, Total 1Parenteral Nutrition 1Organizational Objectives 1Mindfulness-Based Stress Reduction 1Mindfulness 1Methotrexate 1Meditation 1Massage 1Hydrocortisone 1Genetic Testing 1Exercise Test 1Dietary Supplements 1Dietary Fiber 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hematopoietic and Lymphatic System Neoplasm × Spinal Puncture × Clear all
NCT06895473 2026-01-30

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

OHSU Knight Cancer Institute

Phase 2 Recruiting
26 enrolled

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡